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IN REPLY: As Murray notes, appropriate
test ordering belongs firmly in the domain
of quality care and clinical accountability.
In his seminal article on clinical leadership
of healthcare system improvement, Berwick
lists appropriate use of testing and therapy
as the first challenge facing people who wish
to improve healthcare systems in the
developed world.1
Murray also identifies the paucity of
structured educational programs aimed at
providing junior medical staff with the skills
to exercise “knowledge and judgement” in
test ordering. The Royal Australasian
College of Pathologists is seeking to address
this deficiency through the development of
educational modules on test ordering.
It is unlikely, however, that education
alone will curb the increase in test ordering
in Australia. Educational programs for
junior medical staff are notoriously
resource-intensive and difficult to sustain.
In addition, they rarely provide the point-
of-care guidance that seems to be more
effective in sustainably modifying behav-
iour. Such guidance may require test-
ordering software that provides guidelines
for ordering and feedback of individual
performance, or the use of structured test-
stratification programs such as that
described by Stuart et al.2
Improved education, supervision and
point-of-care guidance will prove ineffective
if fears of litigation continue to drive the
behaviour of clinicians. As Carter points
out, concerns about litigation must be
considered in any program aimed at
improving practice. However, although
litigation related to missed diagnosis is a
recurring theme, this may relate more to
time pressures rather than a failure to
perform investigations. Indeed, many mal-
practice suits result from failure to ade-
quately check and act upon the results of
the barrage of tests ordered. Attempts to
reduce medicolegal risk by ordering all
conceivable tests may increase practition-
ers’ risk unless they have extremely well-
designed follow-up systems.
It is important that clinicians not
sacrifice high-quality, evidence-based
investigation and treatment in an attempt
to minimise perceived litigation risks. By
testing inappropriately, clinicians may in
fact expose themselves to greater risks of
litigation, as their patients are exposed to
the risks of the tests themselves, the chance
of false-positive results and inappropriate
treatment, and the failure to follow up on
investigation results.
It is unfortunate, and an indictment of
our current reimbursement system, that the
financial realities of community practice
make it difficult for clinicians to take
sufficient time to communicate with
patients about the appropriateness of an
investigation or treatment. If we continue to
allow this to become the way we practise,
we will continue to see a diminution of our
professional role as we become merely
booking agents for tests.
As Berwick says, “Efforts to reform the
health system from the outside can help
motivate and set the stage for improvement.
Yet, if clinicians do not wish to make
specific changes in their own work to better
meet society’s need for better outcomes and
lower cost, no-one outside the health
system can be clever enough or powerful
enough to make them do it.”1
1. Berwick DM. Eleven worthy aims for clinical leadership of
health system reform. JAMA 1994; 272: 797-802.
2. Stuart PJ, Crooks S, Porton M. An interventional program
for diagnostic testing in the emergency department. Med J
Aust 2002; 177: 131-134. ❏
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TO THE EDITOR: While agreeing that
sensible utilisation of pathology tests in
emergency departments (EDs) is impor-
tant, we are concerned that the article by
Stuart et al1 might be misinterpreted to
justify wholesale reductions in important
diagnostic microbiological tests, particu-
larly blood cultures. Stuart and colleagues
imply they could safely reduce the number
of blood cultures by 80%.1 Other local data
have suggested a minority of blood cultures
in the ED influence patient management.2
Confirmation of aetiology will be denied
for patients by “rationalisation” of blood
cultures in EDs. Although most pathogens
are susceptible to broad-spectrum anti-
microbial agents, widespread empiric pre-
scribing of such agents in an era of
increasing antimicrobial resistance is
unwise.
A recent Australian study evaluating
blood cultures found that a third of patients
with positive blood culture results were not
clinically suspected to be bacteraemic.3
Furthermore, the Journal recently reported
the emergence of community-acquired
methicillin-resistant Staphylococcus aureus
(MRSA),4 and increasing resistance in
Streptococcus pneumoniae.5 Missing MRSA
or multidrug-resistant pneumococcal
bacteraemia will result in adverse patient
outcomes. What about missed cases of
meningococcal disease, or typhoid fever,
with their associated public health costs?
Paradoxically, amid emerging antimicrobial
resistance, we may become less aware of the
problem. Furthermore, what about the
infection control costs required to control
the resultant outbreaks of multidrug-resist-
ant organisms?
Empiric broad-spectrum antibiotic pre-
scribing, driven by failure to undertake
important microbiological investigations, is
bad medicine:
■ It teaches everyone to guess the micro-
biological diagnosis, and, if you do not test,
who can prove you wrong? Perhaps only
when the patient presents to the tertiary
referral hospital with therapeutic failure and
evolving multisystem organ failure.
■ It logically extrapolates to all patients
getting vancomycin plus meropenem to
ensure covering MRSA and resistant gram-
negative bacilli.
■ It inevitably drives resistance, which is
increasing rapidly.
■ It has never been subject to rigorous
scientific scrutiny with cost-effectiveness
studies.
Moreover, the study by Stuart et al1
provides no data on readmission rates,
lengths of stay, adverse events and rates of
missed or incorrect diagnoses; the ED
setting studied has limited generalisability;
and United States guidelines, which may be
inappropriate in the Australian healthcare
context, were used to develop the diagnostic
testing protocol.
Might not reducing the ordering of some
microbiological tests cause “spiralling ther-
apeutic empiricism”? Might not the overall
healthcare budget growth accelerate
because of increased prescribing of expen-
sive broad-spectrum antimicrobials?
1. Stuart PJ, Crooks S, Porton M. An interventional program
for diagnostic testing in the emergency department. Med J
Aust 2002; 177: 131-134.
2. Kelly AM. Clinical impact of blood cultures taken in the
emergency department. J Accident Emerg Med 1998; 15:
254-256.
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Australia. Med J Aust 1999; 170: 152-155. ❏
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TO THE EDITOR: The rate of growth of
pathology and radiology testing over the
last decade has surpassed the average
growth of most other medical services.1
Pathology Medicare items processed per
capita between 1996–97 and 1998–99
demonstrated the largest increase (8%) of
all item types. The interventional program
for reducing diagnostic testing reported by
Stuart, Crooks and Porton shows promise
in addressing this increase in the emer-
gency department, and has significant
potential across other hospital depart-
ments.2
The program’s focus on initiating behav-
ioural change among test-ordering staff as
a precursor to effecting significant long-
term reduction of test use is important.
Views differ as to the reasons for excessive
clinical testing among hospital staff. Medi-
colegal issues, level of experience, fear of
the consequences of inadequate testing
and the desire to diagnose within a single
presentation have been previously
described.3 These issues were dealt with to
some extent via the described educational
component of the authors’ intervention
program and seem to explain the apparent
sustainability of the intervention.
The authors report a “40% decrease in
ordering of tests in the emergency depart-
ment, with test utilisation falling from a
mean of $39.32/patient to $23.72/patient.”
Other measures reported include reduced
time taken for result review, with a
resultant availability of additional
resources for “other critical areas of service
delivery”. An assertion is made that
“improvements to quality care” are
“likely”. Issues relating to improvement in
quality of care, however, still remain:
■ Although “no adverse patient outcomes
relating to underutilisation of investiga-
tions” were identified, what follow-up was
performed to ascertain “adverse out-
comes”?
■ What proportion of patients for whom
further testing was requested via a general
practitioner or outpatient clinic did not
follow through with these investigations?
■ Is there the potential for sufferers of
undiagnosed chronic disease to develop
more serious disease, requiring eventually
more expensive therapies?
■ What is the cost of patients’ attending
GPs and outpatient clinics for further
investigations?
■ Are the investigators’ “evidence-based
list of clinical indicators for ordering . . .
tests” appropriate and are they rigid
enough to prevent operator bias?
Test utilisation measured by cost was the
primary outcome measure for this study.
Based on this measure, the results appear
promising; however, important quality-of-
care issues need investigation before more
widespread implementation is considered.
1. Vining R, Mara P, General practitioners and pathology
testing [editorial]. Med J Aust 1998; 168: 591-592.
2. Stuart PJ, Crooks S, Porton M. An interventional program
for diagnostic testing in the emergency department. Med J
Aust 2002; 177: 131-134.
3. Hammett R, Harris R. Halting the growth in diagnostic
testing [editorial]. Med J Aust 2002; 177: 124-125. ❏
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IN REPLY: Our intervention1 was devel-
oped following concerns with the quality of
test ordering in our department, and
resulted in a significant improvement in
the checking and documentation of test
results. Quality of care is also influenced
by test over- and underutilisation. The
study demonstrated a marked reduction in
test ordering and accorded with the
current estimates for test overutilisation.2
Test underutilisation was monitored using
established mechanisms for reporting crit-
ical incidents (including missed or incor-
rect diagnoses) and patient complaints, as
well as feedback from staff, general
practitioners and other departments and
hospitals. Patient outcome factors (eg,
readmission rates, length of stay) were
confounded by the dramatic onset of
access block during the intervention
period, making retrospective comparisons
unreliable.
The intervention is unlikely to have
increased GP and outpatient referrals, as
the previous practice of the department
had been to refer patients having non-
urgent tests (where the result was not
immediately available) to a GP or outpa-
tient clinic for follow-up of the test result.
The department did not have the resources
to ensure all patients attended for follow-
up of the test result, raising medicolegal
concerns and quality-of-care issues. The
intervention, by deferring the ordering of
non-urgent tests until after review, has the
potential to reduce test duplication and the
ordering of inappropriate (specialised)
tests by junior emergency department
staff. In addition, this process allows the
patient’s condition to be reviewed to
determine whether further or alternative
testing is required.
Gosbell and colleagues speculate on the
potential adverse outcomes that may
follow from a reduction in the routine
ordering of blood cultures. Blood cultures
change patient management in only a
fraction of cases, and the clinical situations
where this occurs have been defined.3 A
major concern is the high rate of false
positive results and the consequent eco-
nomic and social cost of additional
unnecessary testing, treatment and pro-
longed hospital stay.4 As with any clinical
tool, the use of blood cultures must be
supported by evidence-based guidelines
rather than based on expert opinion.
The widespread use of blood cultures to
limit the prescribing of broad-spectrum
antimicrobial agents and development of
disease resistance needs to be subjected to
scientific examination and a cost–benefit
analysis. If, as Gosbell et al seem to argue,
the value of blood cultures lies predomi-
nantly in their public health role, the
public have a right to be informed of the
evidence used to substantiate the “test-all”
approach being advocated to allow proper
debate on the opportunity costs to public
health.
1. Stuart PJ, Crooks S, Porton M. An interventional program
for diagnostic testing in the emergency department. Med J
Aust 2002; 177: 131-134.
2. Van Walraven C, Naylor CD. Do we know what
inappropriate laboratory utilisation is? A systemic review of
laboratory clinical audits. JAMA 1998; 280: 550-558.
3. Kelly AM. Clinical impact of blood cultures taken in the
emergency department. J Accident Emerg Med 1998; 15:
254-256.
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TO THE EDITOR: In advocating the use of
questionnaire measures for outcomes for
patients with depression or anxiety in
clinical practice, Hickie, Andrews and
Davenport advised that “for physicians who
work predominantly in academic, specialist
or administrative settings, the arguments for
routine outcome measurement are obvi-
ous”.1
The arguments are not at all obvious for
clinicians. What is obvious is the divide
between clinical practice and academia.
The claim that there is now “an urgent
need” to promote such questionnaires for
general practitioners is difficult to under-
stand. The historical and professional
resistance to the use of such “instruments”
is for good reason. They are unwieldy and
unreliable. The oldest measure of outcome,
known to clinicians but overlooked by
academics, is to ask the patient “Are you
feeling any better?”, and to evaluate
outcome using clinical skill and expertise.
The key to understanding this peculiar
proposition is to be found in the final
sentence of the article, in its reference to the
move for governments to “support major
service innovations in primary mental
healthcare”. Those who produce, adminis-
ter and measure such innovations will not,
of course, see themselves unrewarded for
their valued efforts to improve healthcare
outcomes in the community. The poor GP
will be burdened with yet another clinically
irrelevant activity.
Hickie and colleagues will no doubt press
on regardless. There is a hint of insight,
however, in the professorial obiter dictum that
these measures would not be “the prime
concern for the treating clinician”. The
“health services planning and other research
benefits” of collating clinical data is a nice
idea. It is hard to see its relevance to general
practice based treatment of psychiatric
disorder. If it is true that one out of three
general practice consultations are driven by
some psychiatric problem, then GPs will
have a lot of forms to fill out, won’t they?
1. Hickie IB, Andrews G, Davenport TA. Measuring outcomes
in patients with depression or anxiety: an essential part of
clinical practice. Med J Aust 2002; 177; 205-207. ❏
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IN REPLY: It is pleasing to note that a senior
psychiatrist is looking at the practicality of
general practitioners (GPs) measuring the
clinical outcome of patients with mental
disorders. However, Dinnen’s concerns
may be groundless. For example, the
Kessler Psychological Distress scale (K10)
consists of 10 simple questions that patients
can complete in two minutes in the waiting
room and doctors can then score by
summing 10 numbers between one and
five.1 This takes less time than writing a
progress note.
The websi tes  www.gpcare.org,
www.beyondblue.org.au and www.mental-
health.gov.au1-3 are the simplest places for
doctors to familiarise themselves with the
proposed outcome measures and with other
new initiatives for better outcomes in
mental healthcare. For the K10, the
website1 advises GPs that if, after treat-
ment, a patient’s score remains above 25 the
GP should review the patient and consider
seeking a second opinion from a psychia-
trist. In a specialist clinic (St Vincent’s
Hospital, Sydney) the average K10 score of
a cohort of patients was 26.1 before
treatment and 21.7 after treatment (indicat-
ing the effect of sound treatment). Never-
theless, the scores of a fifth of patients
remained above 25 after treatment. Psychi-
atrists might therefore familiarise them-
selves with the measure so they understand
when a GP refers a patient for a second
opinion “with a K10 score above 25 after
treatment”.
1. Resources for clinicians. Available at http://www.
gpcare.org (accessed Sep 2002).
2. beyondblue: the national depression initiative. Available at
http://www.beyondblue.org.au (accessed Sep 2002).
3. Better Outcomes in Mental Health Care initiative. Available
at http://www.mentalhealth.gov.au (accessed Sep 2002).❏
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